TY  - GEN
AU  - Cortes,Jorge E
AU  - Heidel,Florian H
AU  - Hellmann,Andrzej
AU  - Fiedler,Walter
AU  - Smith,B Douglas
AU  - Robak,Tadeusz
AU  - Montesinos,Pau
AU  - Pollyea,Daniel A
AU  - DesJardins,Pierre
AU  - Ottmann,Oliver
AU  - Ma,Weidong Wendy
AU  - Shaik,M Naveed
AU  - Laird,A Douglas
AU  - Zeremski,Mirjana
AU  - O'Connell,Ashleigh
AU  - Chan,Geoffrey
AU  - Heuser,Michael
TI  - Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
SN  - 1476-5551
PY  - 2019///0520
KW  - Aged
KW  - Aged, 80 and over
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Benzimidazoles
KW  - Cytarabine
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - Phenylurea Compounds
KW  - Prognosis
KW  - Survival Rate
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41375-018-0312-9
ER  -